Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Saga Pure ASA (SAGA.OL)
Oslo, NO
Saga Pure ASA functions as an investment firm, strategically directing its capital towards burgeoning opportunities within the sustainable economy. Its primary focus encompasses critical sectors such as renewable energy, hydrogen technology, the circular economy, and initiatives aimed at reducing carbon dioxide emissions. The company actively manages a diverse portfolio of both long-term and short-term financial assets. Originally established in 2010 under the name Saga Tankers ASA, the Oslo, Norway-based entity rebranded to Saga Pure ASA in November 2020.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.38% | +0.68% | -0.68% | -5.16% | +8.09% | -2.65% | +11.36% | +3.09% | -48.06% | -44.11% | -88.69% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-245.4% Q1'26: +22.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+103.3% ★ Q1'26: -32.2% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+218.0% Q1'26: -1.5% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+30.6% ★ Q1'26: +66.9% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+1.1% Q1'26: +4.6% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+7.6% Q1'26: +39.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.00× ★ Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
136.19M
est: 152.60M (-10.8%)
|
-19.37M
est: 152.60M (-112.7%)
|
28.16M
est: 152.60M (-81.5%)
|
152.60M
152.60M – 152.60M
+0.0% YoY
|
9.71M
9.71M – 9.71M
-93.6% YoY
|
5.70M
5.70M – 5.70M
-41.3% YoY
|
| EBITDA |
107.10M
est: 142.88M (-25.0%)
|
-32.43M
est: 124.91M (-126.0%)
|
8.62M
est: 124.91M (-93.1%)
|
124.91M
124.91M – 124.91M
+0.0% YoY
|
7.95M
7.95M – 7.95M
-93.6% YoY
|
4.67M
4.67M – 4.67M
-41.3% YoY
|
| EBIT |
107.08M
est: 142.70M (-25.0%)
|
-13.06M
est: 124.90M (-110.5%)
|
8.62M
est: 124.90M (-93.1%)
|
124.90M
124.90M – 124.90M
+0.0% YoY
|
7.95M
7.95M – 7.95M
-93.6% YoY
|
4.66M
4.66M – 4.66M
-41.3% YoY
|
| Net Income |
233.68M
est: 135.77M (+72.1%)
|
2.97M
est: 146.12M (-98.0%)
|
6.48M
est: 146.12M (-95.6%)
|
146.12M
146.12M – 146.12M
+0.0% YoY
|
-26.09M
-26.09M – -26.09M
-117.9% YoY
|
-26.09M
-26.09M – -26.09M
+0.0% YoY
|
| SGA |
13.75M
est: -374.98M (+103.7%)
|
13.06M
est: -376.17M (+103.5%)
|
—
est: -376.17M (+100.0%)
|
-376.17M
-376.17M – -376.17M
+0.0% YoY
|
-23.93M
-23.93M – -23.93M
+93.6% YoY
|
-14.05M
-14.05M – -14.05M
+41.3% YoY
|
| EPS |
0.49
est: 0.28 (+75.0%)
|
0.01
est: 0.28 (-97.8%)
|
0.01
est: 0.28 (-95.6%)
|
0.28
0.28 – 0.28
+0.0% YoY
|
-0.05
-0.05 – -0.05
-117.9% YoY
|
-0.05
-0.05 – -0.05
+0.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-21 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Espen Lundaas | Chief Executive Officer | 3M | male |
| Eldar Paulsrud | Chief Financial Officer | — | male |
| Knut Sandven | Chief Operating Officer | — | male |
| Oyvind Teigen | Chief Technology Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SAGA.OL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
